We are looking for Partners / Distributors in USA 🇺🇸 for our Private Ultra Encrypted Communication Network “EchoLink” — 50% Commission ($9,000 per sale). Click Here
Short Interest Update USMIRA

MIRA Pharmaceuticals Short Squeeze Alert

Mira Pharmaceuticals (MIRA) shows extreme shorting pressure with a 56.6% short ratio.

By The Forensic Ledger Desk September 27, 20261 min read
Company
Mira Pharmaceuticals
Short % Float
56.6%
Days to Cover
1.2

Mira Pharmaceuticals (MIRA) has been identified as an extreme short squeeze candidate. With a short ratio of 56.6%, the stock is seeing significant bearish bets building up. This high level of shorting pressure, combined with its current price of $0.85, suggests that the stock is highly susceptible to volatility and potential short-covering rallies.

Source

Signal data sourced from AltIndex. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.

#Short Squeeze#US Equities

Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.

Commission a Report · The Forensic Ledger Desk

Forensic Research & Investigations

We conduct deep investigative research into publicly traded companies — deploying forensic accountants, field investigators, and industry experts to uncover business fraud (overstated revenues), accounting fraud (inflated profits), or severe fundamental business flaws.

Commission us to compose a short-seller research report on a company you target. Every dossier is built to evidentiary standards — sourced, falsifiable, and ready to move markets.

Commission a Report
Business Fraud

Overstated revenues, fake channels, pulled-forward demand.

Accounting Fraud

Inflated profits, aggressive recognition, hidden liabilities.

Fundamental Flaws

Structural business defects the market has mispriced.